ConditionAngiosarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorItalian Sarcoma Group
About this trial
This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
pathological diagnosis of AS;
any site of origin;
any age;
primary, localized, resectable disease.
Disqualifiers
None
Trial population
* pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Observational
Other interventionObservational
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Pathological diagnosis of AS, any site of origin, any age, primary, localized, resectable disease.1 intervention
Trial outcomes
Primary outcomes
1
Demographic characteristics
Demographic data
Time frame
At the time of enrollment2
General characteristics
Comorbidities
Time frame
At the time of enrollment3
Cancer data
Previous cancer data
Time frame
At the time of enrollment4
Origin of Tumor
Site of origin
Time frame
At the time of enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov